Skip to main content
. 2018 Sep 6;11(6):1343–1349. doi: 10.1016/j.tranon.2018.08.009

Figure 2.

Figure 2

Fold-change in mRNA expression of SLC7A11 (A), TRIM16 (B), SRXN1 (C), or TXNRD1 (D) in a panel of nine breast cell lines. Cells were treated with 50 μM APR-246 or DMSO for 12 hours. Data were analyzed using paired t test. All experiments were carried out in triplicate. Values are means ± SEM, *P > .01, **P > .001, ***P > .0001; p53-mut, p53 mutated; P53-WT; p53 wild-type.